Division of Metabolic Diseases, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy.
Diabetes Res Clin Pract. 2011 Nov;94(2):172-9. doi: 10.1016/j.diabres.2011.06.018. Epub 2011 Jul 12.
The hyperglycemic hyperosmolar syndrome (HHS) is a life-threatening diabetic complication. We aimed to portrait the short and long term outcome after a HHS episode and to describe features associated with increased early mortality.
We collected data from consecutive HHS cases, defined based on rigorous glucose and osmolality criteria. We retrieved anthropometric measures, history of diabetes, other cardiovascular risk factors and chronic co-morbidity. Clinical and biochemical parameters were recorded at admission, after 24h and at discharge. We assessed incidence of complications, as well as short (≤ 30 days) and long term mortality.
Patients were about 80-year old. Fifty-one cases were included, characterized by severe hyperglycemia (55.5 mosm/L) and hyperosmolality (385 mosm/L). Thirty-three percent developed at least one complication. Short term mortality was 16%; lower Glasgow Coma Scale, higher plasma glucose and mild acidosis were predictive of short term mortality. The long term mortality (median follow-up 1.27 years) was not significantly different from historical mortality data after hypoglycemic coma.
In this study, early mortality of HHS was 16% and some clinical features at presentation were predictive of an adverse short term outcome. Long term survival after a HHS episode did not appear to be severely impaired.
高血糖高渗综合征(HHS)是一种危及生命的糖尿病并发症。我们旨在描述 HHS 发作后的短期和长期结局,并描述与早期死亡率增加相关的特征。
我们收集了基于严格的血糖和渗透压标准的连续 HHS 病例的数据。我们检索了人体测量指标、糖尿病史、其他心血管危险因素和慢性合并症。在入院时、24 小时后和出院时记录临床和生化参数。我们评估了并发症的发生率,以及短期(≤30 天)和长期死亡率。
患者年龄约为 80 岁。共纳入 51 例患者,其特征为严重高血糖(55.5 mosm/L)和高渗透压(385 mosm/L)。33%的患者至少发生了一种并发症。短期死亡率为 16%;较低的格拉斯哥昏迷量表评分、较高的血浆葡萄糖和轻度酸中毒是短期死亡率的预测因素。低血糖昏迷后,HHS 的长期死亡率(中位随访 1.27 年)与历史死亡率数据无显著差异。
在这项研究中,HHS 的早期死亡率为 16%,一些发病时的临床特征预示着不良的短期结局。HHS 发作后长期生存似乎没有受到严重损害。